webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Ald-Ph-PEG2-NHS

  CAS No.: 1807521-07-8   Cat No.: BADC-00401   Purity: ≥98% 4.5  

Ald-Ph-PEG2-NHS is a heterobifunctional linker with aldehyde and NHS ester functionalities, enabling site-specific bioconjugation of amine-containing biomolecules and aldehyde-reactive payloads. Its PEG2 spacer increases solubility and flexibility, making it ideal for antibody-drug conjugate linker designs.

Ald-Ph-PEG2-NHS

Structure of 1807521-07-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H22N2O8
Molecular Weight
406.39
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
CHO-Ph-CONH-PEG2-NHS ester; DF-PEG2-NHS; Ald-Ph-PEG2-NHS ester; Ald-Ph-amido-PEG2-C2-NHS ester; 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate; Propanoic acid, 3-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester; Benzamide, N-[2-[2-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy]ethoxy]ethyl]-4-formyl-; N-[2-(2-{3-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy}ethoxy)ethyl]-4-formylbenzamide
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]propanoate
Canonical SMILES
c1cc(ccc1C=O)C(=O)NCCOCCOCCC(=O)ON2C(=O)CCC2=O
InChI
InChI=1S/C19H22N2O8/c22-13-14-1-3-15(4-2-14)19(26)20-8-10-28-12-11-27-9-7-18(25)29-21-16(23)5-6-17(21)24/h1-4,13H,5-12H2,(H,20,26)
InChIKey
GNTMWHHLUUIRGC-UHFFFAOYSA-N
Density
1.35±0.1 g/cm3 (Predicted)
Solubility
Soluble in DCM, DMF, DMSO
Appearance
Pale Yellow or Colorless Oily Matter
Shipping
Room temperature
Storage
Store at 2-8°C

Ald-Ph-PEG2-NHS, a versatile bioconjugation reagent, finds its footing in a diverse spectrum of biomedical and biochemical pursuits. Here are four key applications elaborated with a high level of perplexity and burstiness:

Protein Labeling: A foundational tool in the biologist's arsenal, Ald-Ph-PEG2-NHS assumes a crucial role in the precise labeling of proteins at specific sites. By interacting with primary amines housed within lysine residues, this reagent facilitates the bonding of fluorescent dyes or other molecular reporters. This synergistic alliance allows for exploration into protein localization, interactions, and dynamics through the intricate lens of fluorescence microscopy and other visualization techniques.

Antibody-Drug Conjugates (ADCs): Leading the charge in anticancer breakthroughs, Ald-Ph-PEG2-NHS contributes its expertise to the fusion of cytotoxic drugs with antibodies. This collaboration forges unwavering covalent bonds that orchestrate the targeted delivery of therapeutic payloads to cancerous cells while mitigating collateral damage. Such pinpoint accuracy enhances the efficacy and safety profile of cancer treatments, heralding a new epoch in oncological therapy.

Surface Functionalization: Within the realms of nanotechnology and biomaterials, Ald-Ph-PEG2-NHS plays a pivotal role in customizing surface functionalities. By grafting functional groups onto nanoparticles, beads, or similar materials, it ushers in a realm of opportunities for biomedical applications. This transformation opens doors for attaching biologically active molecules like peptides, antibodies, or ligands, crucial for biosensing, precise drug delivery, and diagnostic assays with finesse and accuracy.

Protein Stabilization: Leading the forefront in protein preservation, Ald-Ph-PEG2-NHS serves as a beacon in enhancing the stability and solubility of proteins. Through the art of pegylation, it shields against aggregation, proteolysis, and immunogenic threats, thereby extending the protein's longevity and bioavailability. This reinforcement proves invaluable in the development of therapeutic interventions and biopharmaceuticals across an array of diseases, embodying the pinnacle of protein preservation science.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Amino-PEG4-alcohol | THP-SS-PEG1-Tos | (2S,2'S)-Bis(2,5-dioxopyrrolidin-1-Yl) 4,4'-disulfanediylbis(2-(((benzyloxy)carbonyl)amino)butanoate) | Anthramcyin | BCN-exo-PEG7-maleimide | Amino-PEG9-propionic acid | H-D-Lys(N3)-OH HCl | 6-Azido-hexylamine | FSP-3 | MAL-di-EG-Val-Cit-PAB-MMAE | Ald-Ph-PEG2-NHS
Send Inquiry
Verification code
Inquiry Basket